Insight Molecular Diagnostics (IMDX) Consolidated Net Income (2015 - 2026)
Insight Molecular Diagnostics (IMDX) posted Consolidated Net Income of -$11.2 million for Q1 2026, up 52.69% sequentially from -$23.8 million in Q4 2025, and down 43.72% YoY from -$20.0 million in Q1 2025.
Insight Molecular Diagnostics (IMDX) Consolidated Net Income (2015 - 2026) Analysis & Trends
Insight Molecular Diagnostics has reported Consolidated Net Income for 12 years, with the latest figure at -$11.2 million in Q1 2026.
- Quarterly Consolidated Net Income fell 43.72% year-over-year to -$11.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$51.1 million (up 8.45% YoY) and the FY2025 annual result came in at -$59.7 million, up 52.45% from the prior year.
- Consolidated Net Income rose to -$11.2 million in Q1 2026 per IMDX's latest filing, from -$23.8 million in the prior quarter.
- Over five years, Consolidated Net Income peaked at -$2.9 million in Q1 2023 and troughed at -$33.9 million in Q4 2024.
- A 5-year average of -$12.4 million and a median of -$8.1 million in 2025 frame the typical range for Consolidated Net Income.
- The sharpest annual moves came in 2023 and 2024: Consolidated Net Income soared 57.46% in 2023, then sank 212.0% in 2024.
- Over 5 years, Consolidated Net Income stood at -$33.0 million in 2022, then jumped by 91.12% to -$2.9 million in 2023, then plunged by 1058.78% to -$33.9 million in 2024, then increased by 29.91% to -$23.8 million in 2025, then surged by 52.69% to -$11.2 million in 2026.
- According to Business Quant data, Consolidated Net Income over the past three periods registered -$11.2 million, -$23.8 million, and -$7.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 1.76 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -66.93 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 339.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 241.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 338.41 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 207.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 232.90 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 299.10 Mn |
| 10 | Insight Molecular Diagnostics | 158.03 Mn | 139.50 Mn | 157,000.00 | -11.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -11.40 Mn |
| Mar 31, 2026 | -9.09 Mn |
| Dec 31, 2025 | -12.89 Mn |
| Sep 30, 2025 | -11.05 Mn |
| Jun 30, 2025 | -9.84 Mn |
| Mar 31, 2025 | -6.80 Mn |
| Dec 31, 2024 | -20.89 Mn |
| Sep 30, 2024 | -13.52 Mn |
| Jun 30, 2024 | -4.95 Mn |
| Mar 31, 2024 | -9.13 Mn |
| Dec 31, 2023 | -15.99 Mn |
| Sep 30, 2023 | -6.49 Mn |
| Jun 30, 2023 | -8.33 Mn |
| Mar 31, 2023 | 3.03 Mn |
| Dec 31, 2022 | -44.98 Mn |
| Sep 30, 2022 | -9.33 Mn |
| Jun 30, 2022 | -8.30 Mn |
| Mar 31, 2022 | -10.29 Mn |
| Dec 31, 2021 | -35.69 Mn |
| Sep 30, 2021 | -13.80 Mn |